MIRXES-B(02629): Zeng Guowei appointed as independent non-executive director
MIRXES-B (02629) announced that Ms. Ma Luling resigned from the positions of Independent Non-Executive Director, Chairman of the Company Nomination Committee, and member of the Company Remuneration Committee, with immediate effect on May 29, 2026, due to her intention to focus on other business pursuits and affairs. The board of directors accepted Ms. Ma Luling's resignation on May 31, 2026.
MIRXES-B (02629) Announcement: Ms. Ma Luling resigned from the position of Independent Non-Executive Director, Chairman of the Company Nomination Committee, and Member of the Company Remuneration Committee with immediate effect on May 29, 2026, in order to focus on other business pursuits and affairs. The Board of Directors accepted her resignation on May 31, 2026.
The Board of Directors resolved on May 31, 2026 to appoint: (a) Dr. Lin Qianli as a member of the Nomination Committee; (b) Mr. Fang Xiao as Chairman of the Nomination Committee; (c) Dr. Zhu Xingfen as a member of the Remuneration Committee, all with immediate effect.
Mr. Zeng Guowei was appointed as an Independent Non-Executive Director on May 31, 2026, with immediate effect, to fill the temporary vacancy created by Ms. Ma Luling's resignation. Therefore, in accordance with the Company's third amended and restated Constitutional Outline and By-laws, Mr. Zeng Guowei's term will last until the first Annual General Meeting of Shareholders following his appointment (i.e. the Company's next Annual General Meeting) and will need to be re-elected by shareholders at that meeting. In addition to being appointed as an Independent Non-Executive Director, Mr. Zeng Guowei was also appointed as a member of the Company Nomination Committee, Remuneration Committee, Audit Committee, and Independent Investigation Committee, with immediate effect.
Related Articles

HK Stock Market Move | MINIMAX-W(00100) opens more than 5% higher, company officially initiates A-share IPO process, introduces MiniMax M3 model today.

HK Stock Market Move | AKESO (09926) opened more than 9%, Evorich Link's combined chemotherapy defeated PD-1 combined chemotherapy OS results released.

YIDU TECH (02158) plans to acquire a online platform with millions of doctors: After reaching the turning point of profitability, AI healthcare enters the "doctor ecosystem" battle.
HK Stock Market Move | MINIMAX-W(00100) opens more than 5% higher, company officially initiates A-share IPO process, introduces MiniMax M3 model today.

HK Stock Market Move | AKESO (09926) opened more than 9%, Evorich Link's combined chemotherapy defeated PD-1 combined chemotherapy OS results released.

YIDU TECH (02158) plans to acquire a online platform with millions of doctors: After reaching the turning point of profitability, AI healthcare enters the "doctor ecosystem" battle.






